They NARROWLY missed the funding, and there will be other funding cycles. It sounded like Mayo wanted a more frequent dosing regiment, and it's really hard to have someone get infusions 3x/day, so I think when they get the oral formulation they'll get the funding.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links